Author

Makala B. Pace

Observed names: Makala B Pace, Makala Pace

Institutions: Huntsman Cancer Institute, University of Utah Health Care

Observed institutions: The University of Texas MD Anderson Cancer Center, University of Utah, Huntsman Cancer Institute, University of Utah Health Care

ORCID: 0000-0003-1132-3377

Observed ORCID: 0000-0003-1132-3377

OpenAlex ID: A5075463494

Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia

2013 · Lauren J. Radvansky, Makala B. Pace, et al. · American Journal of Health-System Pharmacy · 92

The role of trastuzumab in the management of salivary ductal carcinomas.

2013 · Anthony J Perissinotti, Matthew Lee Pierce, et al. · PubMed · 39

Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma

2023 · Nazli Dizman, Ameish Govindarajan, et al. · Clinical Genitourinary Cancer · 33

Malignant pleural mesothelioma

2012 · Sheree E. Chen, Makala B. Pace · American Journal of Health-System Pharmacy · 22

Evaluation of methotrexate clearance with an enteral urine alkalinization protocol for patients receiving high-dose methotrexate

2020 · Elizabeth Kramer, Michael Filtz, et al. · Journal of Oncology Pharmacy Practice · 9

Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment

2009 · Rodney J. Hunter, Makala B. Pace, et al. · Supportive Care in Cancer · 9

Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations

2024 · Arjun Gupta, Michelle Tregear, et al. · JCO Oncology Practice · 8

Association between time-of-day of the immune checkpoint inhibitor (ICI) infusion and disease outcomes among patients with metastatic renal cell carcinoma (mRCC).

2023 · Nazli Dizman, Ameish Govindarajan, et al. · Journal of Clinical Oncology · 5

Evaluating hematology/oncology clinical pharmacist activities via self-reported work sampling

2022 · Julia S Lee, Nancy A Nickman, et al. · American Journal of Health-System Pharmacy · 4

Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network

2023 · Jennifer P Booth, Julie M Kennerly-Shah, et al. · Journal of Oncology Pharmacy Practice · 2

Works count: 10

Citation count: 223

H-index: 7

I10-index: 4